EMERYVILLE, Calif., May 29, 2025 /PRNewswire/ -- Amyris, Inc., a vertically integrated synthetic biology company and leading innovator in the field of industrial biotechnology, today announced ...

Summary "Fit To Win," high ROI Capex and innovative marketing are reducing cash burn equaling 19% of H2 2022 and 26% of 2023 product sales, delivering positive cash flow in 2023.

Amyris, Inc., a vertically integrated synthetic biology company and leading innovator in the field of industrial biotechnology, and Ingredion Incorporated (NYSE: INGR), a leading global provider ...

Biotech firm Amyris Inc on Wednesday said it has filed for Chapter 11 bankruptcy in a U.S. court and is planning to sell its consumer brands to improve the company's liquidity position.

The resignation of Amyris' CEO is likely to be viewed as a positive by many, but the implications of this are negative. Read more about AMRS stock here.

Dive Brief: Amyris successfully auctioned off four of its brands — Pipette, Biossance, 4U and MenoLabs — amid its Chapter 11 bankruptcy, according to a court filing Friday.; Biossance is set ...

EMERYVILLE, Calif., May 29, 2025 /PRNewswire/ -- Amyris, Inc., a vertically integrated synthetic biology company and leading innovator in the field of industrial biotechnology, today announced ...

EMERYVILLE, Calif., May 29, 2025 /PRNewswire/ -- Amyris, Inc., a vertically integrated synthetic biology company and leading innovator in the field of industrial biotechnology, today announced ...

Amyris, Inc., a vertically integrated synthetic biology company and leading innovator in the field of industrial biotechnology, today announced that it has acquired Ingredion's 31% stake in the ...